China Pharmaceutical Industry Bharatbook from its exhaustive collection has come out with a report " China Pharmaceutical Industry " which gives an overview, Demand, Supply Trends and industry analysis reports. Scope * Industry Profile – Structure of China’s Pharmaceutical industry, Industry size and value, statistics and graphs showing the gross industrial output of medical and pharmaceutical products, number of pharmaceutical enterprises in China, Government’s healthcare reform policy, 11th Five-Year Plan, Intellectual Property Rights, Administrative Protection, issues of the China Pharmaceutical Industry, Size of the global pharmaceutical market and industry trends. * Market Trends and Outlook – Development of the Traditional Chinese Medicine Market, Growth and sales of the Over-The-Counter Pharmaceutical Market in China, overview of the generic drugs market in China, research and development encouraged by the government, competitive advantages in China Pharmaceutical research, imports and exports of China Pharmaceuticals, merger and acquisitions of Pharmaceutical companies in China, projections of the China Pharmaceutical market. * Leading players & Comparative Matrix - Company profiles of leading industry players, performance, company key financials, major developments and SWOT analysis of competitors. * Companies mentioned: Harbin Pharmaceutical Group Co.Ltd., Northeast Pharmaceutical Co.Ltd., North China Pharmaceutical Co.Ltd.,Beijing Double-Crane Pharmaceutical Co.Ltd. http://www.bharatbook.com/market-research-reports/healthcaremarket-research-report/china-pharmaceutical-industry.html Summary China Pharmaceuticals includes an overview of China’s pharmaceutical industry, a “pharmerging” market that is likely to grow into the third-largest pharmaceutical market in the world by 2011. Part 1 of the report contains a brief outline of the industry in 2009, explaining the structure and size of the pharmaceutical industry. It also introduces the government policies that have influenced the industry and the various issues that the industry copes with. business credit report Part 2 of the report includes a description of the major pharmaceutical segments, with the current trends and happenings present in the segment. A concise global merger and acquisition outline and market outlook are also included in this part. Part 3 of the report lists the top 100 China’s pharmaceutical enterprises for 2009. Because the industry is very fragmented, this report only includes a few of the leading players with their current developments and three-year financial highlights. The leading players introduced in this report are Harbin Pharmaceutical Group Co., Ltd., Northeast Pharmaceutical Co., Ltd., North China Pharmaceutical Co., Ltd., and Beijing DoubleCrane Pharmaceutical Co., Ltd. A comparative matrix of the companies’ financial